Lobbying

Antheia's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Defense and Health Issues.

Antheia

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Antheia lobbying by quarter
Antheia lobbying by quarter
QuarterAmountReports
Q4 2022$60K1
Q1 2023$60K1
Q2 2023$60K1
Q3 2023$60K1
Q4 2023$60K1
Q1 2024$60K1
Q2 2024$60K1
Q3 2024$60K1
Q4 2024$60K1
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Defense$270K · 9 reports
  • Health issues$270K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Health & Human Services, Dept of (HHS)6 reports
  • Executive Office of the President (EOP)4 reports
  • Export-Import Bank of the United States (EXIM Bank)2 reports
  • Food & Drug Administration (FDA)2 reports
  • Office of Science & Technology Policy (OSTP)2 reports
  • Defense, Dept of (DOD)1 reports
  • Natl Economic Council (NEC)1 reports
  • Office of Management & Budget (OMB)1 reports

Firms it paid

Firm
Invariant$540K15 quarters

Former officials lobbying for it

Former position
BENJAMIN KLEINLegislative Director, Senator Byron Dorgan (2007-2010); Legislative Assistant, Senator Byron Dorgan (2005-2007)Q2 2024
JESSICA HATCHERLeg. Dir, Rep. Jake Auchincloss (2021-2023); Sr. Legislative Asst, Rep. Pramila Jayapal (2020); Leg. Asst, Rep. Pramila Jayapal (2018-2020)Q3 2023

Lobbying reports

Filed by
07/02for Q2InvariantUnder $5,000
04/20for Q1InvariantUnder $5,000
01/18for Q4 2025InvariantUnder $5,000
25/10/19for Q3 2025InvariantUnder $5,000
25/07/17for Q2 2025InvariantUnder $5,000
25/04/21for Q1 2025InvariantUnder $5,000
25/01/20for Q4 2024Invariant$60K
24/10/20for Q3 2024Invariant$60K
24/07/18for Q2 2024Invariant$60K
24/04/21for Q1 2024Invariant$60K
24/01/18for Q4 2023Invariant$60K
23/10/18for Q3 2023Invariant$60K
23/07/17for Q2 2023Invariant$60K
23/04/19for Q1 2023Invariant$60K
23/01/18for Q4 2022Invariant$60K